Confluence Pharmaceuticals

Yamo Pharmaceuticals

This company develops pharmaceutical therapies to treat core social-interaction deficits for individuals with autism spectrum disorder.

Tetra Therapeutics

This biotechnology company develops therapeutic drugs for patients suffering from neurological conditions such as Alzheimer's disease and Fragile X syndrome.

Uncommon Therapeutics

This company develops gene-based medicines for patients with rare neurodevelopmental disorders, with an initial focus on treating Rett Syndrome.

Mahzi Therapeutics

This biotechnology company develops gene and antisense oligonucleotide therapies for patients with rare genetic neurodevelopmental disorders.

Autobahn Therapeutics

This company develops brain-penetrating small molecule therapies for patients with neuropsychiatric and neuroimmunologic disorders, including depression and multiple sclerosis.

MapLight Therapeutics

This company develops targeted therapeutics for patients with brain disorders including schizophrenia, autism spectrum disorder and Parkinson’s disease.

Scioto Biosciences

This company develops live bacterial therapeutics and delivery platforms to treat patients with autism, gastrointestinal disorders and neonatal intestinal conditions.

Pharmasum Therapeutics

This company develops neurological drugs for patients with dementia, Alzheimer's disease and Down syndrome to provide to the global healthcare market.